Janssen Biotech (JNJ) Announces Agreement with Pharmacyclics (PCYC) to Devlop Anti-Cancer Compound
Go back to Janssen Biotech (JNJ) Announces Agreement with Pharmacyclics (PCYC) to Devlop Anti-Cancer Compound| Johnson & Johnson (NYSE: JNJ) | Delayed: 271.19 -2.22 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $273.41 | 52 Week High | $126.07 | |||
| Open | $273.40 | 52 Week Low | $94.28 | |||
| Day High | $273.40 | P/E | 56.38 | |||
| Day Low | $269.86 | EPS | $4.81 | |||
| Volume | 1,269,023 | |||||
| Pharmacyclics, Inc. (NASDAQ: PCYC) | Delayed: 261.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.25 | 52 Week High | $261.68 | |||
| Open | $0.82 | 52 Week Low | $85.50 | |||
| Day High | $261.25 | P/E | 300.29 | |||
| Day Low | $261.25 | EPS | $0.87 | |||
| Volume | 3,226 | |||||
